VIR - Company ID 0001706431
The table below shows Vir Biotechnology, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $232.19M | $222.95M | $241.58M | $848.63M | $347.81M | $436.57M |
| Short-term investments | $228.75M | $678.05M | $1.27B | $1.52B | $217.18M | $300.29M |
| Receivables | - | - | - | $0.00 | $773.08M | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $514.08M |
| $1.04B |
| $1.59B |
| $2.52B |
| $1.56B |
| $772.37M |
| Property, plant & equipment | $55.62M | $63.18M | $96.02M | $105.61M | $42.83M | $17.95M |
| Goodwill | $16.94M | $16.94M | $16.94M | $16.94M | $16.94M | $16.94M |
| Total assets | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $918.76M |
| Accounts payable | $9.80M | $5.08M | $6.33M | $6.42M | $6.52M | $5.08M |
| Total current liabilities | $92.81M | $119.66M | $175.41M | $511.03M | $341.24M | $99.06M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $237.55M | $248.43M | $328.82M | $724.13M | $522.42M | $201.91M |
| Retained earnings | -$1.20B | -$759.78M | -$237.82M | $377.24M | -$138.60M | -$667.18M |
| Total equity | - | - | - | $2.08B | $1.43B | $716.85M |